20-Bio-B10 Biomechanical Device Design & Human Factors · December 2017
Nivaar worked solution (AI-drafted; not reviewed by a licensed engineer)
Paper format: National Exams, December 2017 — 04-Bio-B10 Analytical Biochemistry. Three hours, closed book, any non-communicating Casio/Sharp calculator. Six questions of equal value (20 marks each); five constitute a complete paper and only the first five appearing in the answer book are marked. All six are solved here, because this set is a study resource rather than an examination script. The paper is essay/descriptive throughout, with two embedded PCR copy-number sub-questions (Q2b, Q2c) that carry numeric content.
Reference texts (the books a candidate should have reviewed for this subject):
Question text not reproduced: the examination questions are © Engineers and Geoscientists BC. Open the official past paper (linked at the top of this page) to read the question, then follow the worked solution below.
[Figure not reproduced: Source Figure 1 (redrawn from the printed histogram) — The blue (labeled) sample is bimodal: a low-intensity peak near 1×10 3 that overlaps the pink (unlabeled) control, plus a distinct higher-intensity peak at about 1.3×10 4 — roughly one decade to its right, still short of . See the official exam paper.]
The unlabeled control (pink) shows a single, narrow peak at low fluorescence intensity — this is the population's baseline autofluorescence, with no specific antibody present to generate signal. The antibody-labeled sample (blue) is bimodal: it reproduces that same low-intensity peak (overlapping the pink control almost exactly), plus a second, distinct peak shifted roughly one decade higher — centred a little above 1×104 (about 1.3×104: it sits between the 1e+02 and 1e+05 axis labels, well short of 1e+05) — that has no counterpart in the unlabeled control at all. That second peak can only be explained by cells that specifically bound the fluorescently labeled antibody, and specific antibody binding requires the target epitope — the cell-surface receptor — to be present on the cell surface. The conclusion is therefore that the receptor is present, but not uniformly: the cell population is heterogeneous, splitting into a receptor-positive subpopulation (the new high-intensity peak, the larger of the two peaks by height here) and a receptor-negative (or very-low-expressing) subpopulation that stays at the background/autofluorescence level indistinguishable from the unlabeled control. A simple "receptor present vs. absent" call on the whole population would miss this — the histogram itself is what reveals that the sample is a mixture of two distinct cell states.
As cells stream single-file through the laser interrogation point, a flow cytometer simultaneously records several optical parameters per cell: forward scatter (FSC), roughly proportional to cell size/diameter; side scatter (SSC), sensitive to internal complexity/granularity (nuclear shape, granules, membrane folding); and one or more channels of fluorescence intensity, reporting the abundance of any fluorophore-tagged marker present — surface receptors or antigens via labeled antibodies (as in this question), intracellular proteins with permeabilized staining, DNA content with a DNA-binding dye (for cell-cycle staging), or viability with a live/dead exclusion dye. Because these measurements are made cell-by-cell rather than as a bulk average, flow cytometry also reports population-level statistics — percent-positive, mean/median fluorescence intensity per subpopulation, and (via cell sorting, FACS) the ability to physically separate subpopulations defined by any combination of these parameters, exactly as would be needed to separate the receptor-positive and receptor-negative subpopulations identified in part (a).
At minimum, this experiment needs: (1) the unstained/unlabeled control already shown in Figure 1 (pink) — it defines the baseline autofluorescence and instrument voltage settings against which any labeled sample is compared, and is essential for placing the positive/negative gate correctly. (2) An isotype control — cells incubated with an irrelevant antibody of the same isotype, species, and fluorophore/concentration as the specific anti-receptor antibody, but with no known target on these cells. This distinguishes genuine specific binding from non-specific binding (e.g., Fc-receptor-mediated antibody uptake, or nonspecific "stickiness"), which the unstained control alone cannot rule out. Where available, a known receptor-positive cell line (positive control, confirms the antibody/protocol actually works) and a known receptor-negative cell line (negative control) further validate the assay's specificity and dynamic range. If the panel used more than one fluorophore, single-stain and fluorescence-minus-one (FMO) controls would additionally be needed to set compensation and gating boundaries correctly — not required for this single-colour experiment, but standard practice as soon as multiplexing is introduced.